RecruitingNCT06449547

Risk Factors of Anxiety and Depression in Patients With Herpes Zoster Neuralgia

Risk Factors Analysis of Anxiety and Depression in Patients With Herpes Zoster Neuralgia and Characteristics of Serum Biomarkers and Functional Brain Magnetic Resonance Changes

Sponsor

Huazhong University of Science and Technology

Enrollment

600 participants

Start Date

Jun 21, 2024

Study Type

OBSERVATIONAL

Conditions

Herpes Zoster

Summary

The goal of this observational study is to explore risk factors of anxiety and depression in patients with herpes zoster neuralgia, and the changes of certain serum biomarkers and functional brain magnetic resonance images of these patients.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This observational study looks at the factors that contribute to anxiety and depression in patients suffering from herpes zoster neuralgia — the painful nerve condition that can follow shingles. Researchers aim to identify risk factors so that better mental health support can be provided. **You may be eligible if...** - You are 18 or older - You have been diagnosed with herpes zoster neuralgia (nerve pain from shingles) - You are willing to provide informed consent **You may NOT be eligible if...** - You are unable to complete psychological assessment scales - You have a prior history of mental illness Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTHospital Anxiety and Depression Scale

Hospital Anxiety and Depression Scale questionnaire is used to test patients for anxiety and depression.

Locations(1)

Tongji hospital

Wuhan, Hubei, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06449547

Related Trials

Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control Population

NCT055804581 location

The Analgesic Efficacy and Safety of Venlafaxine for Prevention of Postherpetic Neuralgia in Patients With Acute Herpes Zoster

NCT073617961 location

The Analgesic Efficacy and Safety of Mirogabalin in Patients With Herpes Zoster

NCT073071701 location

A Study to Test GlaxoSmithKline's (GSK) Candidate Vaccine-GSK1437173A for Prevention of Shingles in Children With Kidney Transplant

NCT0400680831 locations

Erector Spinae Plane Block Versus Transcutaneous Radiofrequency in Postherpetic Neuralgia

NCT074006401 location